These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17327229)

  • 1. N-MYC regulates focal adhesion kinase expression in human neuroblastoma.
    Beierle EA; Trujillo A; Nagaram A; Kurenova EV; Finch R; Ma X; Vella J; Cance WG; Golubovskaya VM
    J Biol Chem; 2007 Apr; 282(17):12503-16. PubMed ID: 17327229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAK is a critical regulator of neuroblastoma liver metastasis.
    Lee S; Qiao J; Paul P; O'Connor KL; Evers MB; Chung DH
    Oncotarget; 2012 Dec; 3(12):1576-87. PubMed ID: 23211542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines.
    Beierle EA; Ma X; Trujillo A; Kurenova EV; Cance WG; Golubovskaya VM
    Mol Carcinog; 2010 Mar; 49(3):224-34. PubMed ID: 19885861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
    Megison ML; Stewart JE; Nabers HC; Gillory LA; Beierle EA
    Clin Exp Metastasis; 2013 Jun; 30(5):555-68. PubMed ID: 23208732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.
    Gangoda L; Keerthikumar S; Fonseka P; Edgington LE; Ang CS; Ozcitti C; Bogyo M; Parker BS; Mathivanan S
    Oncotarget; 2015 May; 6(13):11175-90. PubMed ID: 25883214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.
    Golubovskaya VM; Zheng M; Zhang L; Li JL; Cance WG
    BMC Cancer; 2009 Aug; 9():280. PubMed ID: 19671193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
    Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparstolonin B, a novel plant derived compound, arrests cell cycle and induces apoptosis in N-myc amplified and N-myc nonamplified neuroblastoma cells.
    Kumar A; Fan D; Dipette DJ; Singh US
    PLoS One; 2014; 9(5):e96343. PubMed ID: 24788776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses.
    Beierle EA; Massoll NA; Hartwich J; Kurenova EV; Golubovskaya VM; Cance WG; McGrady P; London WB
    Clin Cancer Res; 2008 Jun; 14(11):3299-305. PubMed ID: 18519756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK).
    Bownes LV; Marayati R; Quinn CH; Hutchins SC; Stewart JE; Anderson JC; Willey CD; Datta PK; Beierle EA
    J Pediatr Surg; 2022 Jun; 57(6):1026-1032. PubMed ID: 35272839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.
    Beierle EA; Ma X; Stewart J; Nyberg C; Trujillo A; Cance WG; Golubovskaya VM
    Cell Cycle; 2010 Mar; 9(5):1005-15. PubMed ID: 20160475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines.
    Anaganti S; Fernández-Cuesta L; Langerød A; Hainaut P; Olivier M
    Cancer Lett; 2011 Jan; 300(2):215-24. PubMed ID: 21071137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.
    Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ
    Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
    Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma.
    Romain C; Paul P; Kim KW; Lee S; Qiao J; Chung DH
    J Pediatr Surg; 2014 Jan; 49(1):159-65. PubMed ID: 24439602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
    Golubovskaya V; Kaur A; Cance W
    Biochim Biophys Acta; 2004 May; 1678(2-3):111-25. PubMed ID: 15157737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase.
    Veas-Perez de Tudela M; Delgado-Esteban M; Cuende J; Bolaños JP; Almeida A
    J Neurochem; 2010 May; 113(4):819-25. PubMed ID: 20180881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAK-Src-paxillin system expression and disease outcome in human neuroblastoma.
    Kratimenos P; Koutroulis I; Syriopoulou V; Michailidi C; Delivoria-Papadopoulos M; Klijanienko J; Theocharis S
    Pediatr Hematol Oncol; 2017 May; 34(4):221-230. PubMed ID: 29040002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma.
    Watt F; Watanabe R; Yang W; Agren N; Arvidsson Y; Funa K
    Cancer Gene Ther; 2007 Mar; 14(3):287-96. PubMed ID: 17124508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.